EVOTEC SE INH O.N. (EVT) 2.95 EUR (+3.15%) | Healthcare XETRA

Evotec SE is a biotechnology company focused on drug discovery and the development of therapies for rare and complex diseases.

biotechnology medical-technology

Momentum appears very weak and remains clearly downward, reflecting a lack of buying support and persistent market distrust. Strategically, the case retains speculative appeal for its scientific know-how, but it should above all be seen as a turnaround story that still needs to be executed before any genuine shift in sentiment can be expected.

EVOTEC SE INH O.N.

Trend Analysis of EVOTEC SE INH O.N.

Want to see the full analysis?